Your browser doesn't support javascript.
loading
Monocentric, Retrospective Study on Infectious Complications within One Year after Solid-Organ Transplantation at a Belgian University Hospital.
Van Den Daele, Céline; Martiny, Delphine; Etienne, Isabelle; Kemlin, Delphine; Roussoulières, Ana; Sokolow, Youri; Germanova, Desislava; Gustot, Thierry; Nobile, Leda; Hites, Maya.
Afiliación
  • Van Den Daele C; Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
  • Martiny D; Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB), Department of Microbiologie, Faculté de Médecine et Pharmacie, Université de Mons (UMONS), 7000 Mons, Belgium.
  • Etienne I; Department of Pneumology, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
  • Kemlin D; Department of Nephrology, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
  • Roussoulières A; Department of Cardiology, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
  • Sokolow Y; Department of Thoracic Surgery, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
  • Germanova D; Department of Digestive Surgery, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
  • Gustot T; Department of Transplantation, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
  • Nobile L; Department of Intensive Care Unit, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
  • Hites M; Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles (HUB), 1070 Brussels, Belgium.
Microorganisms ; 12(4)2024 Apr 09.
Article en En | MEDLINE | ID: mdl-38674699
ABSTRACT
The epidemiology, diagnostic methods and management of infectious complications after solid-organ transplantation (SOT) are evolving. The aim of our study is to describe current infectious complications in the year following SOT and risk factors for their development and outcome. We conducted a retrospective study in adult SOT recipients in a Belgian university hospital between 2018 and 2019. We gathered demographic characteristics, comorbidities leading to transplantation, clinical, microbiological, surgery-specific and therapeutic data concerning infectious episodes, and survival status up to one year post-transplantation. Two-hundred-and-thirty-one SOT recipients were included (90 kidneys, 79 livers, 35 lungs, 19 hearts and 8 multiple organs). We observed 381 infections in 143 (62%) patients, due to bacteria (235 (62%)), viruses (67 (18%)), and fungi (32 (8%)). Patients presented a median of two (1-5) infections, and the first infection occurred during the first six months. Nineteen (8%) patients died, eleven (58%) due to infectious causes. Protective factors identified against developing infection were obesity [OR [IC] 0.41 [0.19-0.89]; p = 0.025] and liver transplantation [OR [IC] 0.21 [0.07-0.66]; p = 0.007]. Risk factors identified for developing an infection were lung transplantation [OR [IC] 6.80 [1.17-39.36]; p = 0.032], CMV mismatch [OR [IC] 3.53 [1.45-8.64]; p = 0.006] and neutropenia [OR [IC] 2.87 [1.27-6.47]; p = 0.011]. Risk factors identified for death were inadequate cytomegalovirus prophylaxis, infection severity and absence of pneumococcal vaccination. Post-transplant infections were common. Addressing modifiable risk factors is crucial, such as pneumococcal vaccination.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Microorganisms Año: 2024 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Microorganisms Año: 2024 Tipo del documento: Article País de afiliación: Bélgica